Developing customized, novel rare disease therapies: Meet Rich | The Disruptors

Enabling organizations to develop therapies for Huntington’s disease: Meet Ignacio | The Disruptors

Enabling organizations to develop therapies for Huntington’s disease: Meet Ignacio | The Disruptors

Using open science to accelerate drug development: Meet Aled | The Disruptors

Combining Synthetic and Stem Cell Biology: Meet Mark | The Disruptors

Hope for the Future of ALS - The Disruptors

Combining Synthetic and Stem Cell Biology: Meet Mark | The Disruptors

Ashoka University Founder On Education In The Age Of AI, Leaving PE Firm & More | The Disruptors

Decentralize drug development for rare disease patients: Meet Sanath | The Disruptors

Decentralize drug development for rare disease patients: Meet Sanath | The Disruptors

The Disruptors | Conversations in Science

Conversations in Science | The Disruptors

Vocal & Disco House DJ Mix ✨ Funky, Soulful & Feel-Good Piano Grooves - Journey 005

Fortune India: The Disruptors | Chaitanya Muppala on India’s Craft Chocolate Revolution

Au Vodka | 1 Million Bottles Sold in 2020 🏆

The Hanged-The Trigger

From Zepto to Solving India’s Househelp Problem: How Aayush Agarwal Built Snabbit | The Disruptors

Fortune India: The Disruptors | Apoorva Purohit’s Aazol — Serving purpose with every bite

Bringing effective treatments to people with spinal cord injury: Meet Wise | The Disruptors

RAS Mains 2025 Cut-Off Analysis | Expected vs Reality | The Disruptors Ep. 2

How Equal AI Can Help Reduce Fraud In India? GVK Scion Keshav Reddy Speaks On The Disruptors

Riipen Featured on the Business News Network BNN -- The Disruptors Segment with Bruce Croxon